|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest-bearing deposits in other banks | ||||||||||||||||||||
| Short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $72; 2025, $84) | ||||||||||||||||||||
| Total cash and cash equivalents (includes restricted cash: 2026, $166; 2025, $169) | ||||||||||||||||||||
| Financing receivables, net | ||||||||||||||||||||
| Card Member receivables | ||||||||||||||||||||
| Card Member loans | ||||||||||||||||||||
| Card Balances | ||||||||||||||||||||
| Other Loans | ||||||||||||||||||||
| Financing receivables held for sale | ||||||||||||||||||||
| Investment securities | ||||||||||||||||||||
| Premises and equipment, less accumulated depreciation and amortization: 2026, $13,266; 2025, $12,039 | ||||||||||||||||||||
| Other assets, less reserves for credit losses: 2026, $123; 2025, $86 | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Shareholders’ Equity | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Customer deposits | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Short-term borrowings | ||||||||||||||||||||
| Long-term debt (includes debt issued by consolidated variable interest entities: 2026, $12,177; 2025, $13,022) | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Total long-term debt (includes debt issued by consolidated variable interest entities: 2026, $12,177; 2025, $13,022) | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders’ Equity | ||||||||||||||||||||
| Preferred shares, $1.662/3 par value, authorized 20 million shares; issued and outstanding 1,600 shares as of September 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Common shares, $0.20 par value, authorized 3.6 billion shares; issued and outstanding 671 million shares as of September 30, 2026 and 686 million shares as of December 31, 2025 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity | ||||||||||||||||||||
Loading...
